Results 11 to 20 of about 1,149 (191)

Prevalence and Management of Nonepithelial Ovarian Cancer in a Sub-Saharan African Setting. [PDF]

open access: yesObstet Gynecol Int
Background Nonepithelial ovarian cancers (NEOCs) comprise a group of uncommon malignancies which can be challenging to treat. This broad term includes germ cell tumors, sex cord–stromal tumors, and rare types of ovarian cancer, such as small‐cell carcinomas and sarcomas.
Batu BG   +4 more
europepmc   +2 more sources

Tumor de Krukenberg Associado a Virilização Durante a Gestação: Relato de um Caso e Revisão da Literatura

open access: yesRevista Brasileira de Cancerologia, 2022
O tumor de Krukenberg (TK) é uma entidade rara, caracterizada por neoplasia ovariana secundária a um tumor do trato gastrointestinal, freqüentemente bilateral, volumoso e assintomático.
Cícero de Andrade Urban   +5 more
doaj   +1 more source

Tumores metastáticos de ovário

open access: yesRevista Brasileira de Cancerologia, 2023
Foi feito um estudo retrospectivo de 35 casos de tumores secundários ovarianos. Os tumores ovarianos por metástases correspondem a 6% de todos os tumores ovarianos malignos.
Ernesto de Paula Guedes Neto   +4 more
doaj   +1 more source

Tumor de Krukenberg en paciente joven

open access: yesActa Médica Colombiana, 2022
El tumor de Krukenberg (TK) es una neoplasia ovárica secundaria poco frecuente, que se presenta aproximadamente en 1- 2% de la población de todos los tumores en ovario, en la mayoría de los casos secundario a un tumor primario del tracto gastroentérico, en particular del estómago, colon o recto (1).
Ismael Antonio Nicolás Jurado-Arciniegas   +1 more
openaire   +1 more source

Tumores anexiales incidentales en cirugía abdominal

open access: yesRevista Colombiana de Cirugía, 2021
La posibilidad de encontrar una neoplasia benigna o maligna del ovario, de forma inesperada durante una intervención quirúrgica abdominal, es una realidad para todos los especialistas en cirugía.
Clara Briceño-Morales   +7 more
doaj   +1 more source

Tumor de Krukenberg

open access: yesAnales de la Facultad de Medicina, 2014
Se reporta el caso de una mujer de 37 años de edad, atendida en el Servicio de Cirugía General N.º 5 del Hospital Guillermo Almenara Irigoyen - IPSS, con carcinoma metastásico en el ovario de origen extragenital: tumor de Krukenberg, con células en anillo de sello en un estroma celular derivado del estroma ovárico.
Huaraz, David   +2 more
openaire   +3 more sources

Treatments and overall survival in patients with Krukenberg tumor [PDF]

open access: yes, 2019
BACKGROUND: Krukenberg tumor (KT) is a rare secondary ovarian tumor, primarily localized at the gastrointestinal tract in most cases. KT is related to severe prognosis due to its aggressiveness, diagnostic difficulties and poor treatment efficacy ...
Corcione, Francesco   +9 more
core   +1 more source

China special issue on gastrointestinal tumors‐Improved survival after multidisciplinary team decision for patients with advanced gastrointestinal cancer: A multicenter, noninterventional, controlled study

open access: yesInternational Journal of Cancer, Volume 153, Issue 11, Page 1885-1893, 1 December 2023., 2023
What's new? Although bringing in specialists from different disciplines to discuss and develop treatment recommendations is generally believed to be beneficial to the patient, the survival benefit of implementing multidisciplinary team recommendations in gastrointestinal cancer is unclear.
Qi Zhang   +16 more
wiley   +1 more source

Prognostic factors in Krukenberg tumor [PDF]

open access: yes, 2019
BACKGROUND: Krukenberg tumor (KT) is a rare secondary ovarian tumor. Little is known about clinicopathologic factors affecting prognosis in KT. OBJECTIVE: To assess the prognostic value of clinicopathologic factors in KT through a systematic review ...
Corcione, F.   +10 more
core   +1 more source

Ramucirumab beyond progression plus TAS‐102 in patients with advanced or metastatic esophagogastric adenocarcinoma, after treatment failure on a ramucirumab‐based therapy

open access: yesInternational Journal of Cancer, Volume 153, Issue 10, Page 1726-1733, 15 November 2023., 2023
What's new? This multicenter, non‐randomized, open‐label, investigator‐initiated pilot trial evaluated the efficacy of the combination of VEGFR‐targeting antibody ramucirumab beyond progression with TAS‐102 (trifluridine/tipiracil) in advanced esophagogastric adenocarcinoma.
Thorsten Oliver Goetze   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy